Use of Specific Heparan Sulfate Targets as Therapeutic Treatment Against Human Papillomavirus Infection
Kadambari Suri Background: Though prophylactic vaccines exist, ~80% of people (both men and women) will be infected by human papillomavirus (HPV) during their lifetime. While outcomes of HPV infection vary significantly among individuals, HPV is responsible for about one-third of all cancers – including the majority of cases of cervical…